Processa Pharmaceuticals, Inc. Goodwill, Impairment Loss, Net of Tax
Processa Pharmaceuticals, Inc. (PCSA) reported Goodwill, Impairment Loss, Net of Tax of $390.66 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2017-06-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GoodwillImpairmentLossNetOfTax · last filed 2017-06-19
- Processa Pharmaceuticals, Inc. goodwill, impairment loss, net of tax for the quarter ending 2014-12-31 was $0.00.
- Processa Pharmaceuticals, Inc. goodwill, impairment loss, net of tax for the quarter ending 2014-09-30 was $0.00.
- Processa Pharmaceuticals, Inc. goodwill, impairment loss, net of tax for the quarter ending 2014-06-30 was $0.00.
- Processa Pharmaceuticals, Inc. goodwill, impairment loss, net of tax for the quarter ending 2014-03-31 was $390.66K.
- Processa Pharmaceuticals, Inc. goodwill, impairment loss, net of tax for fiscal 2014 was $390.66K.
| Period end | Goodwill, Impairment Loss, Net of Tax 3 month | Goodwill, Impairment Loss, Net of Tax 6 month | Goodwill, Impairment Loss, Net of Tax 9 month | Goodwill, Impairment Loss, Net of Tax 12 month | Goodwill, Impairment Loss, Net of Tax 36 month |
|---|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-19 | $0.00 derived: sum of 2 quarters · filed 2017-06-19 | $0.00 derived: sum of 3 quarters · filed 2017-06-19 | $390.66K 10-K · filed 2017-06-19 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-01 | $0.00 derived: sum of 2 quarters · filed 2015-12-01 | $390.66K 10-Q · filed 2015-12-01 | ||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | $390.66K 10-Q · filed 2015-08-19 | |||
| 2014-03-31 | $390.66K 10-Q · filed 2015-05-15 | $390.66K 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |